Hot Features
Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
AtriCure Inc is a innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft T... AtriCure Inc is a innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. The company also offers a variety of minimally invasive ablation devices and access tools to facilitate the growing trend in less invasive cardiac and thoracic surgery. Geographically, it generates a majority of its revenue from the United States. Mehr anzeigen
AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management...
AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management...
Worldwide revenue of $115.9 million – an increase of 17.9% year over year U.S. revenue of $95.5 million – an increase of 16.8% year over year Achieved 20% growth on revenues from open appendage...
AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management...
AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management...
AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -1.775 | -5.46237882751 | 32.495 | 32.55 | 29.92 | 450700 | 30.96425951 | CS |
| 4 | -4.93 | -13.8288920056 | 35.65 | 37.33 | 29.92 | 389755 | 33.94652137 | CS |
| 12 | 2.22 | 7.78947368421 | 28.5 | 38.34 | 26.62 | 503412 | 32.44215356 | CS |
| 26 | 9.31 | 43.484353106 | 21.41 | 38.34 | 20.2 | 675145 | 26.86103955 | CS |
| 52 | -5.15 | -14.3574017285 | 35.87 | 39.045 | 18.94 | 682296 | 27.57571613 | CS |
| 156 | -35.98 | -53.9430284858 | 66.7 | 74.845 | 18.94 | 436436 | 36.24366703 | CS |
| 260 | -0.06 | -0.194931773879 | 30.78 | 89.18 | 18.94 | 403181 | 42.25928277 | CS |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
